UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...

BMO Capital Markets upgraded shares of goeasy (TSE:GSY – Free Report) from a market perform rating to an outperform rating in ...

Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney Formation, arguing such a deal would boost scale and broaden investor appeal.

Nutrien Ltd. (TSX and NYSE: NTR) today announced the pricing of US$400 million aggregate principal amount of 4.500 percent ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough multiples on tariff-scenario earnings, effectively ...

BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...

Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...